Cutting edge:: Rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells

被引:92
作者
Byers, AM [1 ]
Kemball, CC [1 ]
Moser, JM [1 ]
Lukacher, AE [1 ]
机构
[1] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA
关键词
D O I
10.4049/jimmunol.171.1.17
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
For viruses that establish persistent infection, continuous immunosurveillance by effector-competent antiviral CD8+ T cells is likely essential for limiting viral replication. Although it is well documented that virus-specific memory CD8(+) T cells synthesize cytokines after short term in vitro stimulation, there is limited evidence that these T cells exhibit cytotoxicity, the dominant antiviral effector function. Here, we show that antiviral CD8(+) T cells in mice acutely infected by polyoma virus, a persistent mouse pathogen, specifically eliminate viral peptide-pulsed donor spleen cells within minutes after adoptive transfer and do so via a perforin-dependent mechanism. Antiviral memory CD8(+) Tcells were similarly capable of rapidly mobilizing potent Ag-specific cytotoxic activity in vivo. These findings strongly support the concept that a cytotoxic effector-memory CD8(+) T cell population operates in vivo to control this persistent viral infection.
引用
收藏
页码:17 / 21
页数:5
相关论文
共 21 条
[1]  
Bachmann MF, 1999, EUR J IMMUNOL, V29, P291, DOI 10.1002/(SICI)1521-4141(199901)29:01<291::AID-IMMU291>3.0.CO
[2]  
2-K
[3]   Cutting edge: Rapid in vivo killing by memory CD8 T cells [J].
Barber, DL ;
Wherry, EJ ;
Ahmed, R .
JOURNAL OF IMMUNOLOGY, 2003, 171 (01) :27-31
[4]   CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection [J].
Chen, G ;
Shankar, P ;
Lange, C ;
Valdez, H ;
Skolnik, PR ;
Wu, LJ ;
Manjunath, N ;
Lieberman, J .
BLOOD, 2001, 98 (01) :156-164
[5]   β2-microglobulin knockout mice are highly susceptible to polyoma virus tumorigenesis [J].
Drake, DR ;
Lukacher, AE .
VIROLOGY, 1998, 252 (01) :275-284
[6]   Epitope-specific evolution of human CD8+ T cell responses from primary to persistent phases of Epstein-Barr virus infection [J].
Hislop, AD ;
Annels, NE ;
Gudgeon, NH ;
Leese, AM ;
Rickinson, AB .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (07) :893-905
[7]   EBV-Specific CD8+ T cell memory:: Relationships between epitope specificity, cell phenotype, and immediate effector function [J].
Hislop, AD ;
Gudgeon, NH ;
Callan, MFC ;
Fazou, C ;
Hasegawa, H ;
Salmon, M ;
Rickinson, AB .
JOURNAL OF IMMUNOLOGY, 2001, 167 (04) :2019-2029
[8]   Molecular and functional profiling of memory CD8 T cell differentiation [J].
Kaech, SM ;
Hemby, S ;
Kersh, E ;
Ahmed, R .
CELL, 2002, 111 (06) :837-851
[9]   Rapid effector function in CD8(+) memory T cells [J].
Lalvani, A ;
Brookes, R ;
Hambleton, S ;
Britton, WJ ;
Hill, AVS ;
McMichael, AJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (06) :859-865
[10]   Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates [J].
Liu, LZ ;
Chahroudi, A ;
Silvestri, G ;
Wernett, ME ;
Kaiser, WJ ;
Safrit, JT ;
Komoriya, A ;
Altman, JD ;
Packard, BZ ;
Feinberg, MB .
NATURE MEDICINE, 2002, 8 (02) :185-189